norfloxacin has been researched along with Hyperlipidemias in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, C | 1 |
| Tian, Y | 1 |
| Yu, J | 1 |
| Zhang, R | 1 |
| Zhang, X | 1 |
| Guo, P | 1 |
1 other study available for norfloxacin and Hyperlipidemias
| Article | Year |
|---|---|
The pandanus tectorius fruit extract (PTF) modulates the gut microbiota and exerts anti-hyperlipidaemic effects.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteroidetes; Blood Glucose; Body Weight; Diet, High-Fa | 2019 |